GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (CHIX:IBTl) » Definitions » Return-on-Tangible-Equity

International Biotechnology Trust (CHIX:IBTL) Return-on-Tangible-Equity : 5.05% (As of Feb. 2025)


View and export this data going back to 2015. Start your Free Trial

What is International Biotechnology Trust Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. International Biotechnology Trust's annualized net income for the quarter that ended in Feb. 2025 was £14.07 Mil. International Biotechnology Trust's average shareholder tangible equity for the quarter that ended in Feb. 2025 was £278.42 Mil. Therefore, International Biotechnology Trust's annualized Return-on-Tangible-Equity for the quarter that ended in Feb. 2025 was 5.05%.

The historical rank and industry rank for International Biotechnology Trust's Return-on-Tangible-Equity or its related term are showing as below:

CHIX:IBTl' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -7.38   Med: 8.47   Max: 34.84
Current: 6.25

During the past 13 years, International Biotechnology Trust's highest Return-on-Tangible-Equity was 34.84%. The lowest was -7.38%. And the median was 8.47%.

CHIX:IBTl's Return-on-Tangible-Equity is ranked better than
83.65% of 1266 companies
in the Biotechnology industry
Industry Median: -42.915 vs CHIX:IBTl: 6.25

International Biotechnology Trust Return-on-Tangible-Equity Historical Data

The historical data trend for International Biotechnology Trust's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Return-on-Tangible-Equity Chart

International Biotechnology Trust Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.41 9.18 -7.38 2.45 14.07

International Biotechnology Trust Semi-Annual Data
Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.69 -7.17 20.35 7.41 5.05

Competitive Comparison of International Biotechnology Trust's Return-on-Tangible-Equity

For the Biotechnology subindustry, International Biotechnology Trust's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Return-on-Tangible-Equity falls into.


;
;

International Biotechnology Trust Return-on-Tangible-Equity Calculation

International Biotechnology Trust's annualized Return-on-Tangible-Equity for the fiscal year that ended in Aug. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Aug. 2024 )  (A: Aug. 2023 )(A: Aug. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Aug. 2024 )  (A: Aug. 2023 )(A: Aug. 2024 )
=38.876/( (270.317+282.265 )/ 2 )
=38.876/276.291
=14.07 %

International Biotechnology Trust's annualized Return-on-Tangible-Equity for the quarter that ended in Feb. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Feb. 2025 )  (Q: Aug. 2024 )(Q: Feb. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Feb. 2025 )  (Q: Aug. 2024 )(Q: Feb. 2025 )
=14.068/( (282.265+274.584)/ 2 )
=14.068/278.4245
=5.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Feb. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


International Biotechnology Trust  (CHIX:IBTl) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


International Biotechnology Trust Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust Business Description

Traded in Other Exchanges
Address
1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust Headlines